Argentum Medical, LLC today issued a response to the recent decision in their patent infringement litigation versus Noble Biomaterials, Inc.
"The most important thing to know is the trial has no impact on our patents and it is business as usual for Argentum," said Gregg Silver, Chairman and CEO of Argentum Medical, LLC. "The case concerned non-patent issues and is currently being appealed. We are confident that our appeal will be successful."
Argentum Medical is an industry leader in antimicrobial silver dressings. The company manufactures more than 60 different combinations and sizes of Silverlon® products, and has developed 14 unique categories of wound, burn and post-surgical dressings. Argentum has sold more than three million dressings to more than 2,000 customers, including the Mayo Clinic, Johns Hopkins University, University of Michigan and the Department of Defense.
This month marks Argentum Medical's 10th anniversary. The company has experienced record sales in 2010, with the Silverlon Surgical Wound Pad and Island Dressings achieving domestic sales growth of more than 300% in the second half of the year.
Silver adds, "The litigation will not affect our customers. We will continue to provide our customers with Silverlon® and our other leading products. We are a financially strong company, and service to our customers will not be affected by any expenses resulting from this lawsuit."
Argentum prides itself on groundbreaking innovation, and has particular success with its Silverlon® Negative Pressure Dressing (NPD), which was named Innovative Product of the Year by Frost and Sullivan in 2006. NPD continues to be one of the company's fastest growing categories today. It was the first antimicrobial silver dressing designed to be utilized with negative pressure wound therapy.
SOURCE Argentum Medical, LLC
Argentum医疗，LLC今天发表了回应，公司最近决定在诺布尔生物材料的专利侵权诉讼与
“最重要的是要知道的是审判并没有影响我们的专利，这是一切照旧为Argentum，” 格雷格说， 银，董事长兼首席执行官Argentum医疗，有限责任公司。 “案件有关的非专利问题，目前正在上诉。我们有信心，我们的呼吁将取得成功。”
Argentum医疗是一个银抗菌敷料行业的佼佼者。该公司生产超过60种不同的组合和Silverlon ®产品规格，并制定了14类独特的伤口，烧伤和手术后的敷料。 Argentum已经售出了超过三百万敷料超过2000家客户，其中包括梅奥诊所， 约翰斯霍普金斯大学，密歇根大学和国防部的。
本月是Argentum医疗的10周年。公司拥有经验丰富的销售记录，2010年，随着Silverlon外科伤口敷料垫及港岛实现国内的销售额超过300％的增长在今年下半年上市。
银补充说：“这次诉讼将不会影响我们的客户。我们将继续提供Silverlon ®和我们的其他主导产品的客户。我们是一家财力雄厚的公司，为广大客户服务不会受到任何影响由此产生的费用起诉。“
Argentum引以自豪的突破性创新本身，与它的Silverlon特别成功®负压敷料（新产品开发），它被评为由Frost＆Sullivan的2006年年度创新产品。新产品开发仍然是公司增长最快的类别之一今天。这是第一次银抗菌敷料旨在与利用负压伤口治疗。